XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2020   45,804    
Beginning balance at Dec. 31, 2020 $ 134,260 $ 510,061 $ 14 $ (375,815)
Increase (Decrease) in Shareholders' Equity        
Net loss (3,289)     (3,289)
Stock-based compensation expense 7,019 $ 7,019    
Stock option exercises (in shares)   359    
Stock option exercises 3,532 $ 3,532    
Shares issued under the Employee Stock Purchase Plan (in shares)   14    
Shares issued under the Employee Stock Purchase Plan 249 $ 249    
Issuance of stock for restricted stock unit vesting (in shares)   76    
Restricted stock withheld for employee tax remittance (in shares)   (28)    
Restricted stock withheld for employee tax remittance (1,501) $ (1,501)    
Unrealized loss on investments (61)   (61)  
Ending balance (in shares) at Mar. 31, 2021   46,225    
Ending balance at Mar. 31, 2021 140,209 $ 519,360 (47) (379,104)
Beginning balance (in shares) at Dec. 31, 2020   45,804    
Beginning balance at Dec. 31, 2020 134,260 $ 510,061 14 (375,815)
Increase (Decrease) in Shareholders' Equity        
Net loss (12,006)      
Unrealized loss on investments (37)      
Ending balance (in shares) at Sep. 30, 2021   46,767    
Ending balance at Sep. 30, 2021 156,780 $ 544,624 (23) (387,821)
Beginning balance (in shares) at Mar. 31, 2021   46,225    
Beginning balance at Mar. 31, 2021 140,209 $ 519,360 (47) (379,104)
Increase (Decrease) in Shareholders' Equity        
Net loss (3,786)     (3,786)
Stock-based compensation expense 10,866 $ 10,866    
Stock option exercises (in shares)   330    
Stock option exercises 3,531 $ 3,531    
Shares issued under the Employee Stock Purchase Plan (in shares)   13    
Shares issued under the Employee Stock Purchase Plan 309 $ 309    
Issuance of stock for restricted stock unit vesting (in shares)   12    
Restricted stock withheld for employee tax remittance (in shares)   (1)    
Restricted stock withheld for employee tax remittance (61) $ (61)    
Unrealized loss on investments 24   24  
Ending balance (in shares) at Jun. 30, 2021   46,579    
Ending balance at Jun. 30, 2021 151,092 $ 534,005 (23) (382,890)
Increase (Decrease) in Shareholders' Equity        
Net loss (4,931)     (4,931)
Stock-based compensation expense 8,596 $ 8,596    
Stock option exercises (in shares)   176    
Stock option exercises 1,676 $ 1,676    
Shares issued under the Employee Stock Purchase Plan (in shares)   9    
Shares issued under the Employee Stock Purchase Plan 404 $ 404    
Issuance of stock for restricted stock unit vesting (in shares)   4    
Restricted stock withheld for employee tax remittance (in shares)   (1)    
Restricted stock withheld for employee tax remittance (57) $ (57)    
Unrealized loss on investments 0      
Ending balance (in shares) at Sep. 30, 2021   46,767    
Ending balance at Sep. 30, 2021 156,780 $ 544,624 (23) (387,821)
Beginning balance (in shares) at Dec. 31, 2021   46,880    
Beginning balance at Dec. 31, 2021 170,462 $ 553,902 (154) (383,286)
Increase (Decrease) in Shareholders' Equity        
Net loss (7,091)     (7,091)
Stock-based compensation expense 9,531 $ 9,531    
Stock option exercises (in shares)   125    
Stock option exercises 1,155 $ 1,155    
Shares issued under the Employee Stock Purchase Plan (in shares)   9    
Shares issued under the Employee Stock Purchase Plan 310 $ 310    
Issuance of stock for restricted stock unit vesting (in shares)   108    
Restricted stock withheld for employee tax remittance (in shares)   (41)    
Restricted stock withheld for employee tax remittance (1,423) $ (1,423)    
Unrealized loss on investments (459)   (459)  
Ending balance (in shares) at Mar. 31, 2022   47,081    
Ending balance at Mar. 31, 2022 172,485 $ 563,475 (613) (390,377)
Beginning balance (in shares) at Dec. 31, 2021   46,880    
Beginning balance at Dec. 31, 2021 170,462 $ 553,902 (154) (383,286)
Increase (Decrease) in Shareholders' Equity        
Net loss (22,631)      
Unrealized loss on investments (992)      
Ending balance (in shares) at Sep. 30, 2022   47,201    
Ending balance at Sep. 30, 2022 177,837 $ 584,900 (1,146) (405,917)
Beginning balance (in shares) at Mar. 31, 2022   47,081    
Beginning balance at Mar. 31, 2022 172,485 $ 563,475 (613) (390,377)
Increase (Decrease) in Shareholders' Equity        
Net loss (8,963)     (8,963)
Stock-based compensation expense 10,808 $ 10,808    
Stock option exercises (in shares)   32    
Stock option exercises 428 $ 428    
Shares issued under the Employee Stock Purchase Plan (in shares)   10    
Shares issued under the Employee Stock Purchase Plan 318 $ 318    
Issuance of stock for restricted stock unit vesting (in shares)   19    
Restricted stock withheld for employee tax remittance (in shares)   (1)    
Restricted stock withheld for employee tax remittance (18) $ (18)    
Unrealized loss on investments (242)   (242)  
Ending balance (in shares) at Jun. 30, 2022   47,141    
Ending balance at Jun. 30, 2022 174,816 $ 575,011 (855) (399,340)
Increase (Decrease) in Shareholders' Equity        
Net loss (6,577)     (6,577)
Stock-based compensation expense 9,104 $ 9,104    
Stock option exercises (in shares)   41    
Stock option exercises 498 $ 498    
Shares issued under the Employee Stock Purchase Plan (in shares)   15    
Shares issued under the Employee Stock Purchase Plan 331 $ 331    
Issuance of stock for restricted stock unit vesting (in shares)   6    
Restricted stock withheld for employee tax remittance (in shares)   (2)    
Restricted stock withheld for employee tax remittance (44) $ (44)    
Unrealized loss on investments (291)   (291)  
Ending balance (in shares) at Sep. 30, 2022   47,201    
Ending balance at Sep. 30, 2022 $ 177,837 $ 584,900 $ (1,146) $ (405,917)